Friday, October 13, 2017

Plus has started enrolments

Time to celebrate as the PLUS Trial has begun taking enrolments. 
For the team at The George Institute and us here at Spiral it’s a major milestone. Enrolments mean the completion of the development stage and advancement towards the target of enrolling 8,800 patients. 

Enrolments also mean the first shipments of study treatment have been delivered. The ordering process, the receipt of shipments at each hospital and then resupply are all handled via our software, Spinnaker.

To reach this point we do a lot of testing of the software and the database used in the trial.  Bryn was kept busy for weeks checking that Spinnaker matched what was requested, after which the team at The George Institute got stuck in and tested the clinical side of things. Enrolment time for us is about making sure everything is ready including:
  • setting up the monitoring
  • cleaning up the database 
  • making sure we are available for technical support on go-live day
  • copying the project to a development server so we are ready for any upcoming changes or issues

Once the project is live” and enrolling patients, our work is not finished, we:
  • continue to monitor the response speed and activity on the project
  • monitor for teething problems
  • do extra testing to double check everything is running smoothly
  • monitor and manage the servers that host the study software and database
We also have some clever automations that run in the background and make sure things are ticking along with the trial. 

We do this for each project and PLUS was no exception. 

Congratulations to the PLUS team at The George Institute and to all the sites participating in the early enrolments. Today, 25 patients are enrolled with only 8,775 to go!

Friday, September 01, 2017

Congratulations to the winner of the Spiral iPad in Queenstown

We were at the ANZICS-CTG Winter Research Forum in Queenstown last week. It was the most fun I’ve ever had at a conference. I especially enjoyed being able to give away an iPad to the best “conference” photo on twitter.
Congratulations to Samantha Bates for her fabulous photo of The Remarkables reflected in her car mirror and the clever caption that went along with it.
The forum provided an informal opportunity for investigators to gain early advice and feedback on research proposals, to explore issues relevant to study design and conduct in ANZ ICUs and to foster a collaborative approach to study development within the CTG. Five of the trials listed on the program are, or will be, using our software; these are TTM2, TAME, TARGET, PLUS and REMAP-CAP. This was a great opportunity for me to learn more about these and other projects; to extend my knowledge of whats it like in the world of ICU research so I can take that back to the software and improve Spinnaker for the people using it.

The winner along with two of our favourites


Tuesday, August 15, 2017

Introducing our new Project Manager


Meet our new Project Manager, Bryn Gilbertson. He has been working as a tester for us, testing on the PLUS Trial, and earlier this month accepted the role of Project Manager.

The role had been mapped out and loaded on our website ready to advertise as soon as we received confirmation of our next project. I knew our next project would tip us into securing an extra person to join our team. That project turned out to be the TTM2 and TAME Trials combined (more about that later).

Bryn adapted quickly to our way of working, our customer focus and the matrix of software we use. He has a neuroscience degree; the TTM2 & TAME Trials are looking at neurological outcomes after people have experienced a cardiac arrest and Bryn has been enjoying reading the protocols for both these trials while he gets up to speed on the project.

Read more about Bryn »

Tuesday, August 08, 2017

See you in Queenstown 23rd-25th August


Spiral is going to the ANZICS-CTG Winter Research Forum in Queenstown. The forum provides an informal opportunity for investigators to gain early advice and feedback on research proposals, to explore issues relevant to study design and conduct in ANZ ICUs and to foster a collaborative approach to study development within the CTG.

We are very pleased and excited to support the ANZICS-CTG community and to attend the forum where we expect to learn more about the trials undertaken by the CTG.

Five of the trials listed on the program are, or will be, using our software; these are TTM2, TAME, TARGET, PLUS and REMAP-CAP. This presents a great opportunity for us to learn more about these and other projects, to gain further insights into the world of ICU research and catch up with everyone that we work with.

Look out for the competition - we will be giving away an iPad for the most relevant photo on Twitter. Details to follow later.

Forum website »